Glen Harbor Capital Management’s Amedisys AMED Stock Holding History

Glen Harbor Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$525K	Hold	4,004	–	–	0.01%	689
2019 Q2	$486K	Hold	4,004	–	–	0.01%	715
2019 Q1	$493K	Hold	4,004	–	–	0.01%	680
2018 Q4	$469K	Hold	4,004	–	–	0.01%	644
2018 Q3	$500K	Buy	4,004 +1,034	+35%	+$114K	0.01%	730
2018 Q2	$254K	Hold	2,970	–	–	0.01%	894
2018 Q1	$179K	Hold	2,970	–	–	﹤0.01%	1006
2017 Q4	$157K	Buy	2,970 +242	+9%	+$12.8K	﹤0.01%	1052
2017 Q3	$153K	Buy	2,728 +352	+15%	+$18.6K	﹤0.01%	1004
2017 Q2	$149K	Buy	2,376 +1,078	+83%	+$62.8K	﹤0.01%	950
2017 Q1	$66K	Sell	1,298 -154	-11%	-$7.34K	﹤0.01%	1063
2016 Q4	$62K	Buy	+1,452	New	+$61.7K	﹤0.01%	1037

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Glen Harbor Capital Management's AMED Position: Q3 2019 in Review

Glen Harbor Capital Management held its Amedisys (AMED) position steady in Q3 2019 at 4,004 shares worth $525K. The position accounts for 0.01% of the portfolio, ranked #689.

Glen Harbor Capital Management first reported a position in AMED in Q4 2016 and has held it in 12 quarters since. 283 funds tracked by Wall St. Rank hold AMED as of Q3 2019.

Glen Harbor Capital Management held 4,004 shares of Amedisys worth $525K as of Q3 2019.
Glen Harbor Capital Management left its Amedisys share count unchanged in Q3 2019.
Amedisys made up 0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #689 holding.
Glen Harbor Capital Management first reported a position in Amedisys in Q4 2016 and has held it in 12 quarters since.
283 funds tracked by Wall St. Rank held Amedisys as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.